Cargando…

Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting

PURPOSE: We aimed to evaluate the long-term outcome of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in patients who underwent both procedures on different sides. METHODS: In this single-center retrospective study (2001–2019), 117 patients (men, N = 78; median age at CEA, 64.4 [inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Dat Tin, Vokó, Boldizsár, Nyárádi, Balázs Bence, Munkácsi, Tamás, Bérczi, Ákos, Vokó, Zoltán, Dósa, Edit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836368/
https://www.ncbi.nlm.nih.gov/pubmed/35148323
http://dx.doi.org/10.1371/journal.pone.0262735
_version_ 1784649661245554688
author Nguyen, Dat Tin
Vokó, Boldizsár
Nyárádi, Balázs Bence
Munkácsi, Tamás
Bérczi, Ákos
Vokó, Zoltán
Dósa, Edit
author_facet Nguyen, Dat Tin
Vokó, Boldizsár
Nyárádi, Balázs Bence
Munkácsi, Tamás
Bérczi, Ákos
Vokó, Zoltán
Dósa, Edit
author_sort Nguyen, Dat Tin
collection PubMed
description PURPOSE: We aimed to evaluate the long-term outcome of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in patients who underwent both procedures on different sides. METHODS: In this single-center retrospective study (2001–2019), 117 patients (men, N = 78; median age at CEA, 64.4 [interquartile range {IQR}, 57.8–72.2] years; median age at CAS, 68.8 [IQR, 61.0–76.0] years) with ≥50% internal carotid artery stenosis who had CEA on one side and CAS on the other side were included. The risk of restenosis was estimated by treatment adjusted for patient and lesion characteristics. RESULTS: Neurological symptoms were significantly more common (41.9% vs 16.2%, P<0.001) and patients had a significantly shorter mean duration of smoking (30.2 [standard deviation {SD}, 22.2] years vs 31.8 [SD, 23.4] years, P<0.001), hypertension (10.1 [SD, 9.8] years vs 13.4 [SD, 9.1] years, P<0.001), hyperlipidemia (3.6 [SD, 6.6] years vs 5.0 [SD, 7.3] years, P = 0.001), and diabetes mellitus (3.9 [SD, 6.9] years vs 5.7 [SD, 8.9] years, P<0.001) before CEA compared to those before CAS. While the prevalence of heavily calcified stenoses on the operated side (25.6% vs 6.8%, P<0.001), the incidence of predominantly echogenic/echogenic plaques (53.0% vs 70.1%, P = 0.011) and suprabulbar lesions (1.7% vs 22.2%, P<0.001) on the stented side was significantly higher. Restenosis rates were 10.4% at 1 year, 22.3% at 5 years, and 33.7% at the end of the follow-up (at 11 years) for CEA, while these were 11.4%, 14.7%, and 17.2%, respectively, for CAS. Cox regression analysis revealed a significantly higher risk of restenosis (hazard ratio [HR], 1.80; 95% confidence interval [CI], 1.05–3.10; P = 0.030) for CEA compared to that for CAS. After adjusting for relevant confounding factors (smoking, hypertension, diabetes mellitus, calcification severity, plaque echogenicity, and lesion location), the estimate effect size materially did not change, although it did not remain statistically significant (HR, 1.85; 95% CI, 0.95–3.60; P = 0.070). CONCLUSION: Intra-patient comparison of CEA and CAS in terms of restenosis tilts the balance toward CAS.
format Online
Article
Text
id pubmed-8836368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88363682022-02-12 Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting Nguyen, Dat Tin Vokó, Boldizsár Nyárádi, Balázs Bence Munkácsi, Tamás Bérczi, Ákos Vokó, Zoltán Dósa, Edit PLoS One Research Article PURPOSE: We aimed to evaluate the long-term outcome of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in patients who underwent both procedures on different sides. METHODS: In this single-center retrospective study (2001–2019), 117 patients (men, N = 78; median age at CEA, 64.4 [interquartile range {IQR}, 57.8–72.2] years; median age at CAS, 68.8 [IQR, 61.0–76.0] years) with ≥50% internal carotid artery stenosis who had CEA on one side and CAS on the other side were included. The risk of restenosis was estimated by treatment adjusted for patient and lesion characteristics. RESULTS: Neurological symptoms were significantly more common (41.9% vs 16.2%, P<0.001) and patients had a significantly shorter mean duration of smoking (30.2 [standard deviation {SD}, 22.2] years vs 31.8 [SD, 23.4] years, P<0.001), hypertension (10.1 [SD, 9.8] years vs 13.4 [SD, 9.1] years, P<0.001), hyperlipidemia (3.6 [SD, 6.6] years vs 5.0 [SD, 7.3] years, P = 0.001), and diabetes mellitus (3.9 [SD, 6.9] years vs 5.7 [SD, 8.9] years, P<0.001) before CEA compared to those before CAS. While the prevalence of heavily calcified stenoses on the operated side (25.6% vs 6.8%, P<0.001), the incidence of predominantly echogenic/echogenic plaques (53.0% vs 70.1%, P = 0.011) and suprabulbar lesions (1.7% vs 22.2%, P<0.001) on the stented side was significantly higher. Restenosis rates were 10.4% at 1 year, 22.3% at 5 years, and 33.7% at the end of the follow-up (at 11 years) for CEA, while these were 11.4%, 14.7%, and 17.2%, respectively, for CAS. Cox regression analysis revealed a significantly higher risk of restenosis (hazard ratio [HR], 1.80; 95% confidence interval [CI], 1.05–3.10; P = 0.030) for CEA compared to that for CAS. After adjusting for relevant confounding factors (smoking, hypertension, diabetes mellitus, calcification severity, plaque echogenicity, and lesion location), the estimate effect size materially did not change, although it did not remain statistically significant (HR, 1.85; 95% CI, 0.95–3.60; P = 0.070). CONCLUSION: Intra-patient comparison of CEA and CAS in terms of restenosis tilts the balance toward CAS. Public Library of Science 2022-02-11 /pmc/articles/PMC8836368/ /pubmed/35148323 http://dx.doi.org/10.1371/journal.pone.0262735 Text en © 2022 Nguyen et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nguyen, Dat Tin
Vokó, Boldizsár
Nyárádi, Balázs Bence
Munkácsi, Tamás
Bérczi, Ákos
Vokó, Zoltán
Dósa, Edit
Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title_full Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title_fullStr Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title_full_unstemmed Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title_short Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
title_sort restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836368/
https://www.ncbi.nlm.nih.gov/pubmed/35148323
http://dx.doi.org/10.1371/journal.pone.0262735
work_keys_str_mv AT nguyendattin restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT vokoboldizsar restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT nyaradibalazsbence restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT munkacsitamas restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT bercziakos restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT vokozoltan restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting
AT dosaedit restenosisratesinpatientswithipsilateralcarotidendarterectomyandcontralateralcarotidarterystenting